deCODE Homepage - www.decode.com deCODE's Therapeutic Pipeline From Genes to Drugs About deCODE genetics Investors - DCGN deCODE services



These deCODE press releases were accurate at the time of their issuance. However, deCODE assumes no obligation to update, correct or otherwise modify any of these press releases.

Reykjavik, Iceland and Basil, Switzerland, November 29, 2001
The discovery points the way to new predictive diagnostic markers and drug targets for RA
Reykjavik, Iceland, November 14, 2001
Reykjavik, Iceland, November 8, 2001
Reykjavik, Iceland, November 7, 2001
These targets offer a uniquely validated drug discovery portfolio for deCODE's expanding downstream development program
Reykjavik, Iceland, October 23, 2001
Reykjavik, Iceland and Basil, Switzerland, September 11, 2001
Reykjavik, Iceland, August 27, 2001
Reykjavik, Iceland, August 14, 2001
Major New Alliances Signed, Revenues Rise Significantly
Reykjavik, Iceland, August 10, 2001
Reykjavik, Iceland, July 25, 2001
Reykjavik, Iceland and Santa Clara, CA, July 24, 2001
Pharmacogenomics Alliance Aims to Benefit Patients, Payers and the Pharmaceutical Industry
Reykjavik, Iceland and Foster City, CA, July 19, 2001
deCODE's genotype analysis tools and Applied Biosystems' instruments and laboratory management software to provide solutions for analyzing the human genome
Reykjavik, Iceland and Basil, Switzerland, July 16, 2001
Reykjavik, Iceland, July 2, 2001
The alliance has a total potential value to deCODE of over $300 million
Reykjavik, Iceland and Copenhagen, Denmark, June 12, 2001
Reykjavik, Iceland and Copenhagen, Denmark, June 12, 2001
The development of DNA-based tests for drug response will help to deliver to each individual patient the safest and most effective treatment regimes
Reykjavik, Iceland, June 5, 2001
Reykjavik, Iceland and Bedford, Massachusetts, May 25, 2001
Reykjavik, Iceland and Basil, Switzerland, May 22, 2001
Reykjavik, Iceland, May 15, 2001
Reykjavik, Iceland, May 11, 2001
Reykjavik, Iceland, March 15, 2001
Reykjavik, Iceland, March 14, 2001
Reykjavik, March 6, 2001
Roche to provide deCODE with major new research funding for work to develop novel DNA-based diagnostic products and medical decision-support tools
Reykjavik, Iceland and Basil, Switzerland, February 14, 2001




www.decode.comSitemapContact deCODE geneticsSubscribe to the deCODE mailing listLegal Notice